The field of pharmacogenetics is changing quickly today. The “common malady basic variations hypothesis†based GWAS have not satisfied the desire in mainstream researchers after a lot of exertion. Interestingly, since NGS can empower us to distinguish all the causative variations (counting both normal and back hereditary variations) this methodology is driving the following wave in pharmacogenetics. Diary of Pharmacogenomics and Pharmacoproteomics is causing huge commitments to our comprehension of pharmacogenetics and will to reclassify the field of customized medication. All things considered, key headways will be seen soon. Huixiao Hong, Next-Generation Sequencing and Its Impact on Pharmacogenetics.
Research Article: Pharmaceutical Biotechnology: Current Research
Research Article: Pharmaceutical Biotechnology: Current Research
Posters & Accepted Abstracts: Der Pharmacia Sinica
Posters & Accepted Abstracts: Der Pharmacia Sinica
Posters & Accepted Abstracts: International Journal of Drug Development and Research
Posters & Accepted Abstracts: International Journal of Drug Development and Research
Posters & Accepted Abstracts: American Journal of Ethnomedicine
Posters & Accepted Abstracts: American Journal of Ethnomedicine
Keynote: International Journal of Drug Development and Research
Keynote: International Journal of Drug Development and Research
Pharmaceutical Biotechnology: Current Research received 45 citations as per Google Scholar report